Related Experiment Videos
[4 families with silent cholinesterase variant]
M J Moreno Monedero1, D Acevedo León, S Caballero Ramón
1Servicios de Análisis Clínicos y Bioquímica Clínica, Hospital Dr. Peset, Valencia.
Revista Espanola De Anestesiologia Y Reanimacion
|May 1, 1990
Summary
Four patients experienced prolonged apnea after succinylcholine administration. Genetic testing revealed silent (Es1) and atypical (Ea11) cholinesterase variants, highlighting the need for preoperative screening to prevent anesthetic complications.
Area of Science:
- Anesthesiology
- Clinical Genetics
- Pharmacology
Background:
- Succinylcholine is a common muscle relaxant used in anesthesia.
- Apnea following succinylcholine administration can occur due to genetic variations in cholinesterase enzymes.
- Identifying these variants is crucial for patient safety during surgical procedures.